Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort [version 1; referees: 2 approved]

Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort [version 1; referees: 2 approved]

Background: IgA nephropathy (IgAN) is the most common primary glomerulonephritis and an important cause of end-stage kidney disease. Unlike the slowly progressive course seen among Caucasian and East Asian subjects (actuarial survival 80-85% over 10 years), in India about 30-40% of patients have nep...

Full description

Bibliographic Details
Main Authors: Suceena Alexander, George T. John, Anila Korula, T. S. Vijayakumar, Vinoi George David, Anjali Mohapatra, Anna T. Valson, Shibu Jacob, Pradeep Mathew Koshy, Gautam Rajan, Elenjickal Elias John, Smita Mary Matthai, L. Jeyaseelan, Babu Ponnusamy, Terence Cook, Charles Pusey, Mohamed R. Daha, John Feehally, Jonathan Barratt, Santosh Varughese
Format: Article
Language:English
Published: Wellcome 2018-07-01
Series:Wellcome Open Research
Online Access:https://wellcomeopenresearch.org/articles/3-91/v1

Internet

https://wellcomeopenresearch.org/articles/3-91/v1

Similar Items